纵横研报
Tag

#家族控股

02Reports
1929.HK logo
·黄金珠宝零售 ·内部研究

Chow Tai Fook Jewellery Group: A Scale Leader in Transition, Priced Around Fair Value

Chow Tai Fook is the scale leader in Greater China branded jewellery, with a mostly franchised mainland network and a profit mix tilting toward higher-margin fixed-price gold products. FY2026 revenue rose 5.3% to HK$94.4 billion while operating profit jumped 27.8% to HK$18.85 billion on richer mix and store rationalisation, yet at HK$11.83 the shares sit around the base-case fair value of HK$12.2 with zero margin of safety and an unresolved debate over margin durability. Rating Hold: a cash-generative, scale-leading franchise re-rating on mix and discipline, but priced around fair value, with a defensible entry only below the conservative fair value of HK$9.8.

Hold
·制药与诊断 ·内部研究

罗氏(Roche)横纵框架深度研究:熬过专利悬崖的诊断+制药巨头,公道价格撞上争议增长

全球体外诊断第一 + 顶级制药(肿瘤/神经/眼科),家族控股、瑞郎计价。熬过专利悬崖、新药已补满约 100 亿美元缺口、集团回到 +7% 恒汇增长,但强瑞郎吞掉报告增速(仅 +2% CHF)。约 16× 前瞻 PE、3% 股息(39 年贵族)、较 2022 高点低 27%,估值公道但增长有争议;减肥迟到是最大期权。评级持有,理想买点 ≤CHF 295。

持有